Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Topical rapamycin for vitiligo
Official title: Daily Topical Rapamycin Therapy for the Treatment of Vitiligo
Status: Closed to new participants
Description:
Medical University of South Carolina plans to enroll about 20 participants. Rapamycin, also called sirolimus, reduces immune-cell activity and is being applied to the skin in this study. Researchers hope it will slow the immune attack on melanocytes and support repigmentation. Systemic sirolimus is sold as Rapamune for transplant rejection prevention and another rare condition; topical treatment for vitiligo is experimental. Possible effects include skin irritation, acne-like bumps, mouth sores, and infections. People age 13 and older may qualify. The study is underway but is no longer accepting new participants.
Start date: July 28, 2022
Completion date: December 01, 2027
Organizer: Medical University of South Carolina
Contact: Ahmad Aleisa, MD
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Is there a link between vitiligo and depression?
Depression and anxiety are often linked with vitiligo, significantly impacting a person’s quality of life. The connection stems from the shared origin of the skin and brain duri...
- Which skin conditions can be mistaken for vitiligo?
Vitiligo is a common skin condition with characteristic milky white patches of irregular shape. However, several other skin conditions exhibit similar symptoms that can lead to ...
- What are risks of oral and topical corticosteroids?
Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.